Liberty Shoes Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 9:02 am

Competitors of Liberty Shoes Ltd

All Competitor Stocks of Liberty Shoes Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:45 am

Below is a detailed analysis of the quarterly data for Liberty Shoes Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 172.79 Cr.. The value appears to be declining and may need further review. It has decreased from 187.66 Cr. (Mar 2025) to 172.79 Cr., marking a decrease of 14.87 Cr..
• For Expenses, as of Jun 2025, the value is 156.82 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 162.53 Cr. (Mar 2025) to 156.82 Cr., marking a decrease of 5.71 Cr..
• For Operating Profit, as of Jun 2025, the value is 15.97 Cr.. The value appears to be declining and may need further review. It has decreased from 25.13 Cr. (Mar 2025) to 15.97 Cr., marking a decrease of 9.16 Cr..
• For OPM %, as of Jun 2025, the value is 9.24%. The value appears to be declining and may need further review. It has decreased from 13.39% (Mar 2025) to 9.24%, marking a decrease of 4.15%.
• For Other Income, as of Jun 2025, the value is 0.22 Cr.. The value appears strong and on an upward trend. It has increased from -0.15 Cr. (Mar 2025) to 0.22 Cr., marking an increase of 0.37 Cr..
• For Interest, as of Jun 2025, the value is 3.82 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.88 Cr. (Mar 2025) to 3.82 Cr., marking a decrease of 0.06 Cr..
• For Depreciation, as of Jun 2025, the value is 7.85 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.50 Cr. (Mar 2025) to 7.85 Cr., marking a decrease of 4.65 Cr..
• For Profit before tax, as of Jun 2025, the value is 4.52 Cr.. The value appears to be declining and may need further review. It has decreased from 8.60 Cr. (Mar 2025) to 4.52 Cr., marking a decrease of 4.08 Cr..
• For Tax %, as of Jun 2025, the value is 26.33%. The value appears to be improving (decreasing) as expected. It has decreased from 34.77% (Mar 2025) to 26.33%, marking a decrease of 8.44%.
• For Net Profit, as of Jun 2025, the value is 3.33 Cr.. The value appears to be declining and may need further review. It has decreased from 5.61 Cr. (Mar 2025) to 3.33 Cr., marking a decrease of 2.28 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.95. The value appears to be declining and may need further review. It has decreased from 3.29 (Mar 2025) to 1.95, marking a decrease of 1.34.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:58 am

Growth

Last Updated: September 5, 2025, 9:45 am

Balance Sheet

Last Updated: November 9, 2025, 2:25 pm

Below is a detailed analysis of the balance sheet data for Liberty Shoes Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 17.00 Cr..
• For Reserves, as of Sep 2025, the value is 211.00 Cr.. The value appears strong and on an upward trend. It has increased from 206.00 Cr. (Mar 2025) to 211.00 Cr., marking an increase of 5.00 Cr..
• For Borrowings, as of Sep 2025, the value is 165.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 156.00 Cr. (Mar 2025) to 165.00 Cr., marking an increase of 9.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 117.00 Cr.. The value appears to be improving (decreasing). It has decreased from 118.00 Cr. (Mar 2025) to 117.00 Cr., marking a decrease of 1.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 511.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 497.00 Cr. (Mar 2025) to 511.00 Cr., marking an increase of 14.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 171.00 Cr.. The value appears to be declining and may need further review. It has decreased from 173.00 Cr. (Mar 2025) to 171.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 336.00 Cr.. The value appears strong and on an upward trend. It has increased from 319.00 Cr. (Mar 2025) to 336.00 Cr., marking an increase of 17.00 Cr..
• For Total Assets, as of Sep 2025, the value is 511.00 Cr.. The value appears strong and on an upward trend. It has increased from 497.00 Cr. (Mar 2025) to 511.00 Cr., marking an increase of 14.00 Cr..

Notably, the Reserves (211.00 Cr.) exceed the Borrowings (165.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Liberty Shoes Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 17, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 16) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 17, the value is 3.75. This value is below the healthy minimum of 5. It has decreased from 5.90 (Mar 16) to 3.75, marking a decrease of 2.15.
• For Diluted EPS (Rs.), as of Mar 17, the value is 3.75. This value is below the healthy minimum of 5. It has decreased from 5.90 (Mar 16) to 3.75, marking a decrease of 2.15.
• For Cash EPS (Rs.), as of Mar 17, the value is 11.73. This value is within the healthy range. It has decreased from 13.82 (Mar 16) to 11.73, marking a decrease of 2.09.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 95.20. It has increased from 91.49 (Mar 16) to 95.20, marking an increase of 3.71.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 95.20. It has increased from 91.49 (Mar 16) to 95.20, marking an increase of 3.71.
• For Revenue From Operations / Share (Rs.), as of Mar 17, the value is 291.67. It has increased from 266.53 (Mar 16) to 291.67, marking an increase of 25.14.
• For PBDIT / Share (Rs.), as of Mar 17, the value is 23.38. This value is within the healthy range. It has decreased from 25.41 (Mar 16) to 23.38, marking a decrease of 2.03.
• For PBIT / Share (Rs.), as of Mar 17, the value is 15.40. This value is within the healthy range. It has decreased from 17.49 (Mar 16) to 15.40, marking a decrease of 2.09.
• For PBT / Share (Rs.), as of Mar 17, the value is 5.87. This value is within the healthy range. It has decreased from 7.18 (Mar 16) to 5.87, marking a decrease of 1.31.
• For Net Profit / Share (Rs.), as of Mar 17, the value is 3.75. This value is within the healthy range. It has decreased from 5.90 (Mar 16) to 3.75, marking a decrease of 2.15.
• For NP After MI And SOA / Share (Rs.), as of Mar 17, the value is 3.75. This value is within the healthy range. It has decreased from 5.90 (Mar 16) to 3.75, marking a decrease of 2.15.
• For PBDIT Margin (%), as of Mar 17, the value is 8.01. This value is below the healthy minimum of 10. It has decreased from 9.53 (Mar 16) to 8.01, marking a decrease of 1.52.
• For PBIT Margin (%), as of Mar 17, the value is 5.28. This value is below the healthy minimum of 10. It has decreased from 6.56 (Mar 16) to 5.28, marking a decrease of 1.28.
• For PBT Margin (%), as of Mar 17, the value is 2.01. This value is below the healthy minimum of 10. It has decreased from 2.69 (Mar 16) to 2.01, marking a decrease of 0.68.
• For Net Profit Margin (%), as of Mar 17, the value is 1.28. This value is below the healthy minimum of 5. It has decreased from 2.21 (Mar 16) to 1.28, marking a decrease of 0.93.
• For NP After MI And SOA Margin (%), as of Mar 17, the value is 1.28. This value is below the healthy minimum of 8. It has decreased from 2.21 (Mar 16) to 1.28, marking a decrease of 0.93.
• For Return on Networth / Equity (%), as of Mar 17, the value is 3.93. This value is below the healthy minimum of 15. It has decreased from 6.44 (Mar 16) to 3.93, marking a decrease of 2.51.
• For Return on Capital Employeed (%), as of Mar 17, the value is 14.72. This value is within the healthy range. It has decreased from 17.39 (Mar 16) to 14.72, marking a decrease of 2.67.
• For Return On Assets (%), as of Mar 17, the value is 1.49. This value is below the healthy minimum of 5. It has decreased from 2.57 (Mar 16) to 1.49, marking a decrease of 1.08.
• For Long Term Debt / Equity (X), as of Mar 17, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.04 (Mar 16) to 0.05, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 17, the value is 0.83. This value is within the healthy range. There is no change compared to the previous period (Mar 16) which recorded 0.83.
• For Asset Turnover Ratio (%), as of Mar 17, the value is 1.22. It has increased from 1.14 (Mar 16) to 1.22, marking an increase of 0.08.
• For Current Ratio (X), as of Mar 17, the value is 1.26. This value is below the healthy minimum of 1.5. It has increased from 1.23 (Mar 16) to 1.26, marking an increase of 0.03.
• For Quick Ratio (X), as of Mar 17, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 16) to 0.59, marking an increase of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 17, the value is 1.21. This value is below the healthy minimum of 4. It has increased from 1.13 (Mar 16) to 1.21, marking an increase of 0.08.
• For Dividend Payout Ratio (NP) (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 16) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 16) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 16) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 16) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 17, the value is 2.52. This value is below the healthy minimum of 3. It has decreased from 2.64 (Mar 16) to 2.52, marking a decrease of 0.12.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 17, the value is 1.43. This value is below the healthy minimum of 3. It has decreased from 1.69 (Mar 16) to 1.43, marking a decrease of 0.26.
• For Enterprise Value (Cr.), as of Mar 17, the value is 424.97. It has increased from 363.87 (Mar 16) to 424.97, marking an increase of 61.10.
• For EV / Net Operating Revenue (X), as of Mar 17, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.80 (Mar 16) to 0.85, marking an increase of 0.05.
• For EV / EBITDA (X), as of Mar 17, the value is 10.67. This value is within the healthy range. It has increased from 8.40 (Mar 16) to 10.67, marking an increase of 2.27.
• For MarketCap / Net Operating Revenue (X), as of Mar 17, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.53 (Mar 16) to 0.59, marking an increase of 0.06.
• For Retention Ratios (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 16) which recorded 0.00.
• For Price / BV (X), as of Mar 17, the value is 1.83. This value is within the healthy range. It has increased from 1.55 (Mar 16) to 1.83, marking an increase of 0.28.
• For Price / Net Operating Revenue (X), as of Mar 17, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.53 (Mar 16) to 0.59, marking an increase of 0.06.
• For EarningsYield, as of Mar 17, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 16) to 0.02, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness